Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg
Clinical trial NCT05569239 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05569239
- Sponsor
- Osivax
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-08
- Primary completion
- 2026-05-29
- Enrollment
- 2850
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.